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End-stage renal disease (ESRD) is associated with increased
propensity to infections, diminished response to vaccination,
impaired cell-mediated immunity, and reduced CD4þ /
CD8þ T-lymphocyte ratio. Four subsets of CD4þ and CD8þ
T cells have been recently identified: naı¨ve cells (as yet
uncommitted), central memory (CM) cells (previously
programmed), and CD45RA-positive and CD45RA-negative
effector memory (EM) cells (programmed to perform specific
effector functions). The effect of ESRD on subpopulations of
T lymphocytes is unclear and was studied here. Twenty-one
hemodialysis patients and 21 age-matched controls were
studied. Pre- and post-dialysis blood samples were obtained
and analyzed by three-color flow cytometry. CD4þ /CD8þ
ratio and the numbers of the naı¨ve and CM CD4þ and
CD8þ T cells were significantly reduced, whereas the
numbers of EM CD4þ and CD8þ T cells were unchanged in
the ESRD group. The reduction of the naı¨ve and CM T-cell
counts in the ESRD group was associated with increased
apoptosis of these cells. Negative correlations were found
between severity of azotemia, oxidative stress, and
hyperphosphatemia with the number of naı¨ve T cells.
Comparison of diabetic with non-diabetic ESRD patients
revealed higher numbers of total CD8þ cells and EM CD8þ
T cells in the diabetic group. Dialysis did not significantly
change the naı¨ve and CM CD4þ or CD8þ cell counts, but
significantly lowered CD8þ EM cell count. Thus, ESRD results
in increased apoptosis and diminished populations of naı¨ve
and CM T lymphocytes. This phenomenon may, in part,
contribute to the impaired immune response in this
population.
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Although bacterial infections have diminished as a cause of
death in the general population, they constitute the second
most common cause of death in the end-stage renal disease
(ESRD) population.1–3 This is thought to be largely owing to
the impaired host immune response in uremia.1,4,5 The
reported immunological abnormalities in ESRD patients
include decreased granulocyte and monocyte/macrophage
phagocytic function,4,6,7 defective antigen presentation by
monocyte/macrophages,4,8,9 reduced antibody production by
B lymphocytes,4,10,11 and impaired T-cell-mediated immu-
nity.4,12,13 The exact mechanisms responsible for these
derangements are not fully understood.
T lymphocytes play a central role in generation of the
adaptive immune response. In the presence of infection,
naı¨ve (pre-immune) T cells recognize epitopes of the
structural molecules expressed by the invading microbe. This
leads to activation, massive expansion, and differentiation of
these cells into two types of antigen-experienced lymphocyte
subsets, short-lived effector T cells and long-lived memory
T cells.14 Once, re-challenged with the same antigen, the
long-lived memory T cells can elicit the full immunologic
response rapidly.14,15 Recently, several studies have identified
two major subsets within the memory cell population,
namely central memory (CM) and effector memory (EM) T
lymphocytes.14,15 The EM T cells have been further divided
into two subpopulations, the CD45RA-negative effector
memory (TEM) and CD45RA-positive effector memory
(TEMRA) T cells14,15 (Figure 1). The EM cells exert effector
functions at the sites of inflammation, whereas the naı¨ve and
CM cells express homing receptors that allow them to lodge
in the secondary lymphoid organs.14–16 A limited number of
studies have examined the distribution and function of
T lymphocytes in the ESRD patients.17–19 However, little
information is available on the effect of ESRD on the naı¨ve
and memory T-lymphocyte subsets. Therefore, we evaluated
T-lymphocyte subsets pre- and post-hemodialysis in a group
of ESRD patients and compared the results with those
obtained in a group of age-matched control individuals.
RESULTS
General data
Data are summarized in Tables 1 and 2. The underlying cau-
ses of ESRD were diabetic nephropathy in 12, hypertension
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in three, chronic glomerulonephritis in five patients, and
polycystic kidney disease in one. The types of vascular access
included A-V fistulas in 14 and A-V grafts in seven patients.
As expected, serum creatinine and blood urea nitrogen
concentrations were significantly higher in the ESRD patients
compared to the control group. Likewise, serum concentra-
tions of phosphorus, triglylcerides, and lipid peroxidation
product, malondialdehyde (MDA), were significantly elevated
in the ESRD group. Blood hemoglobin concentration was
significantly lower, whereas serum ferritin level and transferin
saturation were higher in ESRD patients than the corre-
sponding values found in the control group. However, serum
cholesterol, albumin, and calcium concentrations in the
ESRD patients were not significantly different from those
observed in the control group. The mean Kt/V value in the
ESRD patients was greater than 1.5, reflecting adequacy of
dialysis regimen in the study participants. In the pre-dialysis
samples, total white blood cell counts and the number of
granulocytes and monocytes were significantly higher in the
ESRD patients as compared to the corresponding values
found in the control group. However, the total lymphocyte
count and CD8þ T-cell count in the pre-dialysis blood
samples were not significantly different from the correspond-
ing values in the control group. As expected, the number of
CD4þ cells and the ratio of CD4þ to CD8þ cells were
significantly reduced in the ESRD group.
T-lymphocyte subset data
Data are shown in Figures 2–8. The ESRD patients exhibited a
marked reduction of the naı¨ve subsets of CD4þ and CD8þ
T cells as compared to the corresponding values in the
normal control group (Figure 2). Likewise, the CM subsets
of both CD4þ and CD8þ T cells were reduced in the ESRD
group (Figures 3 and 4). However, EM subsets (TEM and
TEMRA) of the CD4þ and CD8þ T cells in the ESRD
group were not significantly different from those observed in
the control group (Figures 3 and 4).
Comparison of data obtained in the diabetic (n¼ 12) and
non-diabetic (n¼ 9) ESRD patients revealed higher numbers
of CD8þ T cells and EM T-cell subsets (TEM and TEMRA)
in the diabetic ESRD patients (Figures 5 and 6). However, the
number of naı¨ve and CM cells did not significantly differ
among the diabetic and non-diabetic subgroups. Comparison
of data obtained before and after a 3-h hemodialysis
treatment revealed significant reductions in total white blood
cell count, monocytes, lymphocyte, and CD8þ T cells after
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Figure 1 | A linear model of central and effector T-cell memory
generation in primary response to infection.
Table 1 | Clinical and biochemical parameters in normal
control and ESRD groups
Control (n=21) ESRD (n=21) P-value
Age (years) 4671.8 4973.4 NS
BUN (mg/dl) 13.3371.02 69.2874.66 o0.001
Creatinine (mg/dl) 0.8570.18 10.4570.63 o0.001
Calcium (mg/dl) 9.1470.24 9.1070.20 NS
Phosphorus (mg/dl) 3.2070.16 5.4370.30 o0.001
iPTH (pg/ml) 40.0073.84 293.95757.45 o0.001
Hemoglobin (g/dl) 14.0370.38 11.7270.23 o0.001
Ferritin (ng/ml) 32.6376.26 209.90723.79 o0.001
Transferin saturation (%) 18.6672.12 26.8072.15 0.012
Albumin (g/dl) 3.870.14 3.9770.43 NS
Cholesterol (mg/dl) 159.5075.47 139.0977.09 0.031
Triglyceride (mg/dl) 100.16715.51 146.71716.80 0.052
MDA (mmol/l) 1.7270.08 2.0170.06 o0.001
Kt/V — 1.5370.16 —
BUN, blood urea nitrogen; ESRD, end-stage renal disease; iPTH, immunoreactive
parathyroid hormone; MDA, malondialdehyde; NS, nonsignificant.
Table 2 | Leukocyte and differential counts in normal control
and ESRD groups
Test Controls Pre-dialysis Post-dialysis
Leukocytes (cells/mm3) 58527187 68037499a 60147454b
Neutrophils (cells/mm3) 34337169 44907435a 40527389b
Monocyte (cells/mm3) 4157122 5237192a 3477147b
Lymphocyte (cells/mm3) 17957108 15577118 13677118a,b
CD4+/CD8+ (ratio) 2.6370.34 1.8170.21a 2.4270.27b
ESRD, end-stage renal disease.
aPo0.05 compared to controls.
bPo0.05 compared to pre-dialysis.
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Figure 2 | Distribution of CD4þ and CD8þ T cells in control and
ESRD groups. *Po0.05.
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Figure 3 | Distribution of naı¨ve, CM, TEM, and TEMRA
subpopulations of CD4þ T lymphocytes in the control and
ESRD groups. *Po0.05.
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Figure 4 | Distribution of naı¨ve, CM, TEM, and TEMRA
subpopulations of CD8þ T lymphocytes in the control and
ESRD groups. *Po0.05.
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Figure 5 | Distribution of CD4þ and CD8þ T cells in diabetic
(DM, n¼ 12) and non-diabetic (n¼ 9) ESRD patients. *Po0.05.
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Figure 6 | Distribution of naı¨ve, CM, TEM, and TEMRA
subpopulations of CD8þ T lymphocytes in diabetic (DM)
and non-diabetic ESRD patients. *Po0.05.
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Figure 7 | Effect of hemodialysis on naı¨ve, CM, TEM, and TEMRA
subpopulations of CD8þ T lymphocytes. *Po0.05 vs pre-dialysis.
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Figure 8 | Homing receptor (CCR7)-positive T-cell apoptosis,
assessed by Annexin V staining in ESRD and control groups.
*Po0.05.
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dialysis. Hemodialysis did not change the distribution of
subsets of CD4þ cells but slightly lowered the numbers of
EM subsets (TEM and TEMRA) of the CD8þ cells
(Figure 7).
Apoptosis data
Compared to the controls, the ESRD patients exhibited a
significant increase in apoptosis of both CCR7þ CD4þ and
CCR7þ CD8þ T cells (Figure 8). CCR7þ cells include
naı¨ve and CM T cells.
Correlations
A significant inverse correlation was found between severity
of azotemia (blood urea nitrogen and creatinine concentra-
tions) and the number of naı¨ve and CM subsets of
T lymphocytes (r¼065, Po0.001 and r¼0.54, Po0.001,
respectively). Similarly, significant negative correlations were
noted between number of naı¨ve CD4þ T lymphocytes and
plasma MDA (a marker of oxidative stress) (r¼0.34,
Po0.01), serum phosphorus levels (r¼0.54, Po0.001),
and neutrophil counts (r¼0.305, P¼ 0.017). Similar
negative correlations were noted between the above para-
meters and the numbers of CD4þ CM cells (r¼0.307,
P¼ 0.016) (Figure 9). In contrast, neutrophil and leukocyte
counts were directly correlated with the TEMRAþ CD8þ
cell counts (r¼ 0.516, P¼ 0.000 and r¼ 0.589, P¼ 0.000,
respectively) .
DISCUSSION
The results presented here demonstrate that the numbers of
naı¨ve and CM CD4þ and CD8þT cells are significantly
reduced in the peripheral blood of ESRD patients as
compared to those found in the normal control group. The
observed reduction in the number and proportion of naı¨ve
and CM subsets was not associated with a significant change
in the proportion of the EM T-cell subsets.
In the initial stages of adaptive immune response,
exposure to antigen leads to clonal expansion and differ-
entiation of antigen-specific naı¨ve T cells, resulting in
generation of the memory T cells and effector T cells.14
Effector T cells perform their effector function via secretion
of cytokines and destruction of target cells. At the conclusion
of an immune response, effector T-cell populations contract
and only a small number of the given memory T cells are
maintained.14,15 According to the linear model of T-cell
differentiation, naı¨ve and CM T cells give rise to TEM and
TEMRA cells.14,15 Naı¨ve and CM subsets of T cells are
essential for generation of a robust immune response.14,15
Therefore, the observed reduction of the naı¨ve and CM
T cells in ESRD patients may, in part, contribute to diminished
response to vaccination and increased predisposition to
infections in the ESRD population.
The underlying mechanism responsible for the selective
reductions of the naı¨ve and CM T cells in the peripheral
blood of ESRD patients is not known. The reduction of the
given T-cell subpopulations in peripheral blood may be due
either to increased apoptosis or accelerated activation and
differentiation of T cells into EM T-cell subsets.5,13,20 The
latter is plausible as dialysis-dependent patients are com-
monly subject to repetitive exposure to microbial products
and other antigenic stimulations that may lead to accelerated
turn over and exhaustion of the naı¨ve and CM T cells. In
addition, accelerated apoptosis found in the present study
contributes to the observed reductions of naı¨ve and CM
T cells in the ESRD patients. It is of note that in a study of
ESRD patients, Matsumoto et al.12 found accelerated T-cell
apoptosis via death receptor Fas (CD95) and its ligand FAS L
(CD95L), which are members of the tumor necrosis factor
receptor/ligand superfamily. Similarly, Meier et al.5 found
accelerated apoptosis of the activated T cells (CD69þ
T cells) in as yet untreated and hemodialysis-treated uremic
patients. Alvarez-Lara et al.21 reported that in uremia, Th1
lymphocytes are more prone to apoptosis than Th2 cells. In
addition, Moser et al.13 demonstrated increased T-lympho-
cyte apoptotic cell death in ESRD patients. They further
showed that CD45ROþ memory cells, which include CM
cells, are especially susceptible to apoptotic cell death.
Taken together, the above observations suggest that the
reduction in the numbers of naı¨ve and CM T cells in uremic
patients found here may be due to heightened susceptibility
of these cells to apoptosis. It is not entirely clear as to whether
chronic uremia, per se, or the maintenance hemodialysis
procedure is responsible for the observed increased apoptosis
and diminished numbers of naı¨ve and CM T cells in this
population. However, increased T-cell apoptosis found in
as yet undialyzed ESRD patients points to the role of uremia,
per se, in this process.5 Potential factors that may contribute
to increased apoptosis and altered distribution of lymphocyte
subsets in ESRD patients include uremic toxins,4,11 stress
hormones,11,22 and the treatment modalities among
others.1,18 In this context, the numbers of naı¨ve subsets of
T cells were negatively related to severity of azotemia in our
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Figure 9 | Correlations between serum concentrations of urea
nitrogen, creatinine, MDA, and phosphorous with the number of
CD4þ naı¨ve T lymphocytes in ESRD and control groups.
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ESRD patients. This observation points to the contribution
of uremic toxicity to the pathogenesis of naı¨ve T-cell
lymphopenia. In addition, the inverse correlation between
MDA, a marker of oxidative stress, and the number of naı¨ve
T-cell subset suggests the possible role of reactive oxygen
species in this process. This presumption is of particular
relevance, as the naı¨ve and CM T-cell subsets are exquisitely
vulnerable to oxidative stress.23 As oxidative stress is a
constant feature of ESRD,24 accumulation of uremic toxins
and presence of oxidative stress may work in concert to lower
the numbers of these important subsets of T lymphocytes.
Phosphate retention and hyperphosphatemia, which are
common consequences of renal failure, result in a wide array
of disorders including secondary hyperparathyroidism and
dysregulation of cytosolic Ca2þ concentration. In an earlier
study, Alexiewicz et al.6 showed that impaired phagocytosis
by neutrophilic granulocytes in ESRD patients is associated
with, and is in part due to, elevation of resting cytosolic
Ca2þ concentration, an event that is driven by hyperpar-
athyroidism. The present study revealed a negative correla-
tion between severity of hyperphosphatemia (a main cause of
ESRD-induced secondary hyperparathyroidism) and the
number of naı¨ve subsets of T lymphocytes. This observation
suggests that hyperphosphatemia and secondary hyperpar-
athyroidism may be involved in this process. Further studies
are needed to explore this possibility.
The numbers of EM subsets of CD8þ cells declined
significantly after dialysis compared to the baseline values.
The reason for the observed reduction of CD8þ EM cell
subset following hemodialysis is not known and requires
further investigation. Comparison of diabetic and non-
diabetic patients revealed significantly higher total CD8þ ,
TEM, and TEMRAþ cell counts in the former group. The
reason for the observed difference is not clear. However, this
may be due to a greater immunological stimulation in
response to advanced glycation end products, repetitive
injections (i.e. insulin) among other factors.
In conclusion, ESRD patients exhibit a marked reduction
of the naı¨ve and CM T-cell subsets. This is associated with,
and is at least in part due to, increased apoptosis of these
cells. Given the central role of these subsets of T lymphocytes
in orchestrating the immune response to the de novo
exposure or re-exposure to pathogenic organisms, the defects
identified here may, in part, contribute to increased
susceptibility of ESRD population to various infections.
MATERIALS AND METHODS
Patients
The study protocol was approved by Human Subjects Institutional
Review Board of the University of California Irvine and was
completed with the assistance of the University of California General
Clinical Research Center.
Twenty-one patients with ESRD maintained on hemodialysis for
a minimum of 3 months were recruited for the study. Individuals
with evidence of acute or chronic infection, acute intercurrent
illnesses, and those receiving immunosuppressive drugs were
excluded. Medical history, systolic and diastolic blood pressures
(pre- and post-dialysis), body weight, interdialytic weight change,
routine monthly laboratory data, and dialysis prescription including
dialyzer type and medications were recorded. Pre- and post-dialysis
blood samples were obtained.
A group of 21 normal age-matched control subjects were also
studied. Control subjects exhibiting acute or chronic infection, acute
intercurrent illnesses, and chronic illnesses such as hypertension,
diabetes, malignancy, psychiatric disorders, or those requiring
chronic medications were excluded. A brief medical history was
obtained after informed consent was signed. Blood was obtained by
venipuncture. All participants provided informed consent before
enrollment in the study.
Blood collection
In all ESRD patients, whole blood was collected after canulation of
the vascular access was completed but before the initiation of
dialysis. Post-dialysis samples were obtained form the venous
dialysis tubing. The blood samples were obtained using a needle
and syringe, applying gentle aspiration to minimize shear stress.
Blood samples form the control individuals were collected from a
peripheral vein in the same manner. Total leukocyte and differential
counts were obtained.
Mononuclear cell preparation
Peripheral blood mononuclear cells were isolated from heparinized
blood by gradient centrifugation method using lymphocyte separa-
tion medium (Mediatech Inc., Herndon, VA, USA). A 6 ml volume
of heparinized blood was added to 6 ml of calcium- and
magnesium-free 1 Hank’s balanced salt solution (Irvine Scientific,
Santa Ana, CA, USA). The mixture was slowly added to 12 ml of
lymphocyte separation medium and centrifuged at 5G (221C) for
30 min. Peripheral blood mononuclear cell layer was collected,
washed twice with phosphate-buffered saline (PBS), and resus-
pended in 1 Hank’s balanced salt solution.
Immunostaining
T-lymphocyte subsets were analyzed by three-color flow cytometry
using peridinin chlorophyll protein (PerCP)-conjugated anti-CD4
and anti-CD8 monoclonal antibodies (mAbs) (6 mg/ml PBS; Becton-
Dickinson, San Jose, CA, USA), fluorescein isothiocyanate-con-
jugated anti-CD45RA mAb (50 mg/ml PBS; Becton-Dickinson, San
Jose, CA, USA), and phycoerythrin-conjugated anti-CCR7 anti-
bodies (25 mg/ml PBS; R & D System, Minneapolis, MN, USA). A
200 ml volume of whole blood drawn from the peripheral vein was
incubated with 20 ml of each of the above antibodies for 20 min at
room temperature in dark. The cells were then incubated in 2 ml of
fluorescence-activated cell sorting lysing solution (Becton-Dick-
inson, San Jose, CA, USA) for 15 min to lyse red blood cells. The
cells were then washed twice with PBS to remove red blood cell
remnants and leukocytes were resuspended in 0.5 ml of 1%
paraformaldehyde and used for flow cytometry.
Flow cytometry
Lymphocyte phenotyping was carried out by three-color analysis
using a FACSort flow cytometer and CellQuest software (Becton-
Dickinson). For each sample, data from 10 000 cells were collected
and analyzed. Forward and side scatters were used to gate and
exclude cellular debris and FL3 channels were used to gate CD4þ
and CD8þ T cells. During analysis, an electronic gate was placed on
CD4þ or CD8þ T cells. The associated expression of CD45RA vs
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CCR7 was then used to obtain the percentages of cells uniquely
identifying naı¨ve (CD45RAþ , CCR7þ ), TCM (CD45RA,
CCR7þ ), TEM (CD45RA, CCR7), and TEMRA (CD45RAþ ,
CCR7) subsets of CD 4þ or CD8þ T cells.
Detection of apoptosis
Apoptosis was measured by Annexin V-fluorescein isothiocyanate
binding assay according to the manufacturer’s instructions (CalTag,
Burlingame, CA, USA). Briefly, peripheral blood mononuclear cells
(0.5 106) were stained with 10 ml of PerCP-conjugated anti-CD4/
anti-CD8 and phycoerythrin-conjugated anti-CCR7 mAb, washed
with 2 ml of PBS, and resuspended in 100ml of Annexin V-conjugate
binding buffer) to which 5 ml of fluorescein isothiocyanate-
conjugated Annexin V was added. The mixture was incubated in
dark at room temperature for 15 min, after which 400 ml of binding
buffer was added and 5000 cells were acquired and analyzed by
fluorescence-activated cell sorting. FL3 channels were used to gate
CD4þ and CD8þ T cells. An electronic gate was placed on CCR7
PEþ T cells (which includes naı¨ve and CM cells) and population of
cells positive for Annexin V-fluorescein isothiocyanate was analyzed
using green fluorescence (FL1) on the x axis against cell numbers on
the y axis.
Malondialdehyde assay
Plasma concentration of MDA was measured by high-performance
liquid chromatography as described in our previous studies.25
Data analysis
Quadrant statistics and histogram statistics were used in dot plot of
CellQuest and histogram plot software. Relative proportion and
calculated absolute numbers of CD4þ and CD8þ T lymphocytes
and their subsets of controls, pre-dialysis, and post-dialysis groups
were analyzed with independent and paired sample t-tests in SPSS.
Likewise, Annexin V data were analyzed using the independent
t-test. Data were expressed as mean7s.e. P-values less than 0.05
were considered significant.
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